Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System
JACC: Cardiovascular Interventions · 2025
DOI: 10.1016/j.jcin.2025.07.019 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025. Verfasst von Thomas Waggoner und 41 weiteren Autor:innen. Beteiligte Einrichtung: US Heart & Vascular Tucson Medical Center, Tucson, Arizona, USA. Electronic address: Thomas.Waggoner@usheartandvascular.com. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Mitral Valve, Heart Valve Prosthesis, Cardiac Catheterization. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Edwards Lifesciences Corporation.
Abstract (Originalsprache)
BACKGROUND: The PASCAL Precision transcatheter valve repair system provides a new option for treating prohibitive surgical risk patients with significant, symptomatic degenerative mitral regurgitation (DMR). OBJECTIVES: The authors report early U.S. commercial experience with the PASCAL Precision system. METHODS: Patients with DMR treated with the PASCAL Precision system in the United States were analyzed from the STS/ACC TVT Registry. Procedural, clinical, echocardiographic, functional, and quality-of-life outcomes to 30 days were assessed. All outcomes, including echocardiographic assessments, were site-assessed. RESULTS: In 1,995 DMR patients, the median age was 81.6 years, and 57.0% were male. Median STS-PROM for mitral valve repair was 3.6%, and 69.4% were in NYHA functional class III/IV. Mixed etiology (DMR + other etiology) was present in 11.4%, and 66.9% had complex anatomy (annular/leaflet calcification, mitral valve area
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- US Heart & Vascular Tucson Medical Center, Tucson, Arizona, USA. Electronic address: Thomas.Waggoner@usheartandvascular.com.
- The Christ Hospital, Cincinnati, Ohio, USA.
- Cedars-Sinai Medical Center, Los Angeles, California, USA.
- Montefiore Medical Center, Bronx, New York, USA. Electronic address: https://twitter.com/azeemlatib.
- Atlantic Health System Morristown Medical Center, Morristown, New Jersey, USA.
- Oregon Health & Science University, Portland, Oregon, USA.
Förderung
- Edwards Lifesciences Corporation
Zitieren
APA
Waggoner, T., Garcia, S., Chakravarty, T., Makar, M., Latib, A., Kipperman, R. M., Zahr, F., Hanson, I., Sinha, A. K., Sharma, R. P., Depta, J. P., Castellanos, J. A., Kodali, S., Krishnaswamy, A., Whisenant, B., Menees, D., Lim, D. S., Gilani, F., Sanchez, C. E., …, & Makkar, R. (2025). Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2025.07.019
Vancouver
Waggoner T, Garcia S, Chakravarty T, Makar M, Latib A, Kipperman RM, et al. Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System. JACC: Cardiovascular Interventions. 2025. doi:10.1016/j.jcin.2025.07.019
BibTeX
@article{Waggoner2025,
author = {Waggoner, Thomas and Garcia, Santiago and Chakravarty, Tarun and Makar, Moody and Latib, Azeem and Kipperman, Robert M and Zahr, Firas and Hanson, Ivan and Sinha, Anjan K and Sharma, Rahul P and Depta, Jeremiah P and Castellanos, Jorge A and Kodali, Susheel and Krishnaswamy, Amar and Whisenant, Brian and Menees, Daniel and Lim, D Scott and Gilani, Fahad and Sanchez, Carlos E and Gheewala, Neil and Gada, Hemal and Kapadia, Samir and Ramanathan, P Kasi and Shah, Pinak B and Renard, Brian and Theodos, Gus and Yaryura, Ricardo and Gardner, Blake and Steinberg, Daniel H and Gnall, Eric and Kaddissi, Georges and Chhatriwalla, Adnan K and Frangieh, Antonio H and Eleid, Mackram F and Géneréux, Philippe and Saxon, John T and Villablanca, Pedro and Matar, Fadi and Agarwal, Himanshu and Chetcuti, Stanley and Frisoli, Tiberio and Makkar, Raj},
title = {Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System},
journal = {JACC: Cardiovascular Interventions},
year = {2025},
doi = {10.1016/j.jcin.2025.07.019}
}
EUVIMED